NB PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NB PHARMA
Largest movements
- Receivables within one year +€90,167
up €90,167 (+32.7%), from €275,840 to €366,007
of which Other amounts receivable: +€69,228
- Tangible fixed assets -€26,188
down €26,188 (-10.3%), from €253,333 to €227,146
of which Plant, machinery and equipment: -€27,304
- Reserves +€56,725
up €56,725 (+66.5%), from €85,274 to €141,999
- Trade debts +€16,156
up €16,156 (+12.7%), from €126,817 to €142,973
- Staff costs -€36,780
down €36,780 (-18.9%), from €194,893 to €158,114
- Gross operating margin -€24,477
down €24,477 (-8.2%), from €296,749 to €272,272
From the 31-12-2024 result to the 31-12-2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 31-12-2024 and 31-12-2025 balance sheets and the 31-12-2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 31-12-2024 | 31-12-2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €670,774 | €745,538 | +€74,764 | +11.1% |
| Fixed assets | 21/28 | €253,333 | €227,146 | -€26,188 | -10.3% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €253,333 | €227,146 | -€26,188 | -10.3% |
| Land and buildings | 22 | €53,105 | €52,531 | -€573 | -1.1% |
| Plant, machinery and equipment | 23 | €195,111 | €167,806 | -€27,304 | -14.0% |
| Furniture and vehicles | 24 | €5,118 | €6,808 | +€1,690 | +33.0% |
| Current assets | 29/58 | €417,441 | €518,393 | +€100,952 | +24.2% |
| Stocks and contracts in progress | 3 | €133,214 | €136,906 | +€3,692 | +2.8% |
| Stocks | 30/36 | €133,214 | €136,906 | +€3,692 | +2.8% |
| Amounts receivable within one year | 40/41 | €275,840 | €366,007 | +€90,167 | +32.7% |
| Trade receivables | 40 | €71,796 | €92,735 | +€20,940 | +29.2% |
| Other amounts receivable | 41 | €204,044 | €273,272 | +€69,228 | +33.9% |
| Cash at bank and in hand | 54/58 | €8,387 | €13,228 | +€4,841 | +57.7% |
| Deferred charges and accrued income | 490/1 | - | €2,252 | +€2,252 | |
| Total equity and liabilities | 10/49 | €670,774 | €745,538 | +€74,764 | +11.1% |
| Equity | 10/15 | €517,232 | €573,958 | +€56,725 | +11.0% |
| Contributions | 10/11 | €431,959 | €431,959 | = | 0.0% |
| Reserves | 13 | €85,274 | €141,999 | +€56,725 | +66.5% |
| Distributable reserves | 133 | €85,274 | €141,999 | +€56,725 | +66.5% |
| Amounts payable | 17/49 | €153,542 | €171,581 | +€18,039 | +11.7% |
| Amounts payable within one year | 42/48 | €153,542 | €171,581 | +€18,039 | +11.7% |
| Trade debts | 44 | €126,817 | €142,973 | +€16,156 | +12.7% |
| Suppliers | 440/4 | €126,817 | €142,973 | +€16,156 | +12.7% |
| Taxes, remuneration and social security | 45 | €26,724 | €28,608 | +€1,883 | +7.0% |
| Taxes | 450/3 | €3,174 | €10,290 | +€7,116 | +224% |
| Remuneration and social security | 454/9 | €23,551 | €18,318 | -€5,233 | -22.2% |
| Remuneration, social security and pensions | 62 | €194,893 | €158,114 | -€36,780 | -18.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €33,857 | €36,423 | +€2,566 | +7.6% |
| Other operating charges | 640/8 | €8,433 | €6,528 | -€1,904 | -22.6% |
| Gross operating margin | 9900 | €296,749 | €272,272 | -€24,477 | -8.2% |
| Operating profit (loss) | 9901 | €59,566 | €71,207 | +€11,641 | +19.5% |
| Financial income | 75/76B | €6,765 | €6,788 | +€23 | +0.3% |
| Recurring financial income | 75 | €6,765 | €6,788 | +€23 | +0.3% |
| Financial charges | 65/66B | €1,170 | €1,240 | +€69 | +5.9% |
| Recurring financial charges | 65 | €1,170 | €1,240 | +€69 | +5.9% |
| Profit (loss) for the period before taxes | 9903 | €65,161 | €76,756 | +€11,594 | +17.8% |
| Income taxes | 67/77 | €17,632 | €20,030 | +€2,398 | +13.6% |
| Profit (loss) for the period | 9904 | €47,529 | €56,725 | +€9,196 | +19.3% |
| Profit (loss) for the period to be appropriated | 9905 | €47,529 | €56,725 | +€9,196 | +19.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.